Wolf Ruprecht Wiedemeyer

Wolf Ruprecht Wiedemeyer, PhD, currently serves as Senior Director of Discovery Biology at Revolution Medicines, having previously held the role of Executive Director and Head of Biology at BridGene Biosciences, Inc. With extensive experience in oncology research, Wiedemeyer worked as a Principal Scientist at AbbVie and as an Assistant Professor at UCLA, where teaching involved gynecologic oncology fellows. Research contributions include significant findings on CDK inhibitors and glioblastoma genomic alterations during postdoctoral fellowships at Dana-Farber Cancer Institute and DKFZ German Cancer Research Center. Educational credentials include a PhD in Tumor Genetics from RPTU Kaiserslautern-Landau and postdoctoral studies at Harvard Medical School.